U.S. Markets closed

Gilead Sciences, Inc.'s Best Investment of 2017 (Hint: It Wasn't Kite Pharmaceuticals)

newsfeedback@fool.com (Brian Orelli)
Gilead Sciences, Inc.'s Best Investment of 2017 (Hint: It Wasn't Kite Pharmaceuticals)

Kite is a good buy, but this investment will have a bigger short-term effect.